These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 135563)

  • 1. Total serum cholesterol and urinary dehydroepiandrosterone in humans.
    Lopez-S A; Wingo C; Hebert JA
    Atherosclerosis; 1976 Sep; 24(3):471-81. PubMed ID: 135563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and dehydroepiandrosterone excretion in normal subjects.
    Sonka J; Fassati M; Fassati P; Gregorová I; Picek K
    J Lipid Res; 1968 Nov; 9(6):769-72. PubMed ID: 4234799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
    Luo S; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Aug; 138(8):3387-94. PubMed ID: 9231792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms.
    Nestler JE; Usiskin KS; Barlascini CO; Welty DF; Clore JN; Blackard WG
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1040-6. PubMed ID: 2529264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum dehydroepiandrosterone sulfate concentration is a predictor for deterioration of urinary albumin excretion in male patients with type 2 diabetes.
    Fukui M; Kitagawa Y; Kamiuchi K; Hasegawa G; Yoshikawa T; Nakamura N
    Diabetes Res Clin Pract; 2006 Jul; 73(1):47-50. PubMed ID: 16413943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients.
    Folan MM; Stone RA; Pittenger AL; Stoffel JA; Hess MM; Kroboth PD
    Crit Care Med; 2001 May; 29(5):965-70. PubMed ID: 11378605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal C19 steroids and serum lipoprotein levels in healthy men.
    Vatalas IA; Dionyssiou-Asteriou A
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):388-93. PubMed ID: 12055703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease--preliminary study].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):904-10. PubMed ID: 16821209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years.
    Remer T; Boye KR; Hartmann MF; Wudy SA
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2015-21. PubMed ID: 15671100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography.
    Herrington DM; Gordon GB; Achuff SC; Trejo JF; Weisman HF; Kwiterovich PO; Pearson TA
    J Am Coll Cardiol; 1990 Nov; 16(6):862-70. PubMed ID: 2146310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.
    Gordon GB; Bush DE; Weisman HF
    J Clin Invest; 1988 Aug; 82(2):712-20. PubMed ID: 2969922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary excretion of dehydroepiandrosterone and its metabolites in normal young adult women].
    Takeyasu M; Kato T
    Rinsho Byori; 1998 Dec; 46(12):1241-6. PubMed ID: 9916511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Derivatives of dehydroepiandrosterone and their changes during a one-day starvation test].
    Matoulek M; Hampl R; Svacina S; Sulcová J; Haas T
    Cas Lek Cesk; 2000 Dec; 139(24):772-5. PubMed ID: 11262916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.
    Lobo RA; Paul WL; Goebelsmann U
    Obstet Gynecol; 1981 Jan; 57(1):69-73. PubMed ID: 6450345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey.
    Christopher-Hennings J; Kurzman ID; Haffa AL; Kemnitz JW; Macewen EG
    In Vivo; 1995; 9(5):415-20. PubMed ID: 8900917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.
    Tivesten Å; Vandenput L; Carlzon D; Nilsson M; Karlsson MK; Ljunggren Ö; Barrett-Connor E; Mellström D; Ohlsson C
    J Am Coll Cardiol; 2014 Oct; 64(17):1801-10. PubMed ID: 25443702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P; Cusan L; Gomez JL; Bélanger A; Labrie F
    J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.
    Martel C; Sourla A; Pelletier G; Labrie C; Fournier M; Picard S; Li S; Stojanovic M; Labrie F
    J Endocrinol; 1998 Jun; 157(3):433-42. PubMed ID: 9691976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiological survey of risk factors for ischemic heart disease in 42,804 men. I. Serum cholesterol value.
    Van Houte O; Kesteloot H
    Acta Cardiol; 1972; 27(5):527-64. PubMed ID: 4539690
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
    Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.